WATCH: Nestle said it might divest some of its brands and that its underperforming vitamins business was under review https://t.co/xEixW3Ul4N https://t.co/liBB1eFCe6
Nestle said it was reviewing its underperforming vitamins business that could lead to divestment of some brands, after reporting its first-half sales volumes grew slower than analysts' expectations https://t.co/RQ6o6F6P34 https://t.co/YkQLimlQwp
Nestle to review vitamins business as 2025 first-half organic sales beat forecast https://t.co/uvj1GuKzL0 https://t.co/uvj1GuKzL0
Nestlé reported its first-half 2025 earnings with sales totaling CHF 44.23 billion, slightly below the estimated CHF 44.65 billion. The company posted organic revenue growth of 2.9%, marginally surpassing the estimate of 2.88%, while real internal growth was 0.2%, below the anticipated 0.47%. Pricing growth contributed 2.7%, exceeding expectations. The underlying trading operating margin stood at 16.5%, higher than the forecasted 15.9%. Sales volume growth was slower than analysts had expected, with price increases helping to offset the sluggish demand. In response to the performance, Nestlé announced it is reviewing its underperforming vitamins business, including the Nature’s Bounty brand, which it acquired for $5.75 billion in 2021. This review could lead to divestment of some vitamin supplement brands as the company aims to refocus on premium offerings. The company also provided 2025 guidance but did not disclose specific details in the report.